Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001181431-12-010609

Options or other derivatives

  • Director acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

FRYKMAN EDWARD W · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2012-02-16 Grant or award : show line 1 in the form Stock Option −15,000 32,000 D
Loading xslF345X03/rrd334921.xml…